India’s bioeconomy surges to US$190 billion as science and technology transform economic growth

India’s bioeconomy has expanded from approximately US$10 billion in 2014 to more than US$190 billion in 2026, marking one of the fastest growth rates in the global biotechnology sector, as reported by IANS, a TV BRICS partner.

The remarkable expansion reflects a broader transformation of India’s research and development ecosystem, which has become a key driver of economic growth, industrial modernisation and technological self-reliance. With a national target of reaching US$300 billion by 2030, the country is accelerating investments in biotechnology, genomics, healthcare innovation and advanced scientific research.

The biotechnology sector has emerged as a cornerstone of this growth, supported by advances in diagnostics, precision medicine, biopharmaceuticals and genomic technologies. India has increasingly developed home-grown solutions for major health challenges, strengthening its position as a global centre for biotechnology innovation while expanding access to advanced healthcare technologies.

The country’s scientific progress extends well beyond biotechnology. Over the past decade, India has recorded significant achievements in strategic sectors, including space exploration, weather forecasting and advanced engineering. The successful lunar mission to the Moon’s south polar region elevated India’s status among leading spacefaring nations, while a rapidly expanding innovation ecosystem has stimulated technological development across multiple industries.

At the same time, advances in meteorological science have improved forecasting accuracy and strengthened disaster preparedness capabilities, supporting agriculture, infrastructure planning and climate resilience. Indigenous technologies are now being integrated into a growing number of sectors.

With biotechnology, healthcare innovation, space research and advanced technologies increasingly contributing to national development, India is positioning itself as a major global hub for scientific excellence. The country’s ambition to expand its bioeconomy to US$300 billion by 2030 highlights the growing importance of research and innovation as engines of future economic transformation.